Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Announcement on Voluntary Disclosure of Approval of New Drug Marketing Application for Deutenzalutamide Soft Capsules

· Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Approval of New Drug Marketing Application for Deutenzalutamide Soft Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis